PDB ID: 2Y81
Hetero Atom Contents
The number of atoms exceeds 100,000. So, it can not be displayed here.
Select unit:
Select hetatm:
Select chain: Sequence
Data format:
Color scheme of protein:
| Code | Name | Style | Show | Link | |
|---|---|---|---|---|---|
| 931 | 6-chloro-N-((3s)-2-oxo-1-{4-[(2r)-2--pyrrolidinyl] phenyl}-3-pyrrolidinyl)-2-naphthalenesulfonamide | PoSSuM | |||
| CA | Calcium ion | PoSSuM | |||
| MG | Magnesium ion | PoSSuM |
| Code | Name | Show |
|---|
| Code | Name | Emphasize |
|---|
| Code | Name | Show |
|---|
Download interaction data: 2Y81
Structure summary
| Code : | 2Y81 PDBj RCSB PDB PDBe | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Header : | BLOOD CLOTTING | ||||||||||||||||||||||||
| Title : | Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs | ||||||||||||||||||||||||
| Release Data : | 2011-03-16 | ||||||||||||||||||||||||
| Compound : |
|
||||||||||||||||||||||||
| Source : |
|
||||||||||||||||||||||||
| Authors : | Young, R.J., Adams, C., Blows, M., Brown, D., Burns-Kurtis, C.L., Chaudry, L., Chan, C., Convery, M.A., Davies, D.E., Exall, A.M., Foster, G., Harling, J.D., Hortense, E., Irving, W.R., Irvine, S., Jackson, S., Kleanthous, S., Pateman, A.J., Patikis, A.N., Roethka, T.J., Senger, S., Stelman, G.J., Toomey, J.R., West, R.I., Whittaker, C., Zhou, P., Watson, N.S. | ||||||||||||||||||||||||
| Keywords : | BLOOD CLOTTING, HYDROLASE, SERINE PROTEASE, BLOOD COAGULATION PROTEASE | ||||||||||||||||||||||||
| Exp. method : | X-RAY DIFFRACTION ( 1.70 Å ) | ||||||||||||||||||||||||
| Citation : |
Structure and Property Based Design of Factor Xa Inhibitors: Pyrrolidin-2-Ones with Aminoindane and Phenylpyrrolidine P4 Motifs.
Young, R.J.,Adams, C.,Blows, M.
et al.
PubMed: 21349710 |
||||||||||||||||||||||||
Reaction
| Chain : | B | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| UniProt : | P00742 (FA10_HUMAN) | ||||||||
|
|||||||||


